Tag Archive for: Carb-X

CARB-X
Antibiotic resistance

Antimicrobial resistance: Q&A with CARB-X about the fight against AMR

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is an industry alliance to support research and development projects in AMR. Since its inception in 2016, CARB-X has supported 114 R&D projects across 14 countries, leading to 18 projects advancing into or completing clinical trials. EBM talked to CARB-X Executive Director Kevin Outterson.

Read more
vaccine

Swiss vaccine developer Limma Tech get CARB-X grant

Swiss multivalent vaccine developer LimmaTech Biologics AG has been awarded US$2.2m rom the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X).

Read more